Clinical trials / Iowa
Psychedelic and ketamine trials recruiting in Iowa
3 trials registered on ClinicalTrials.gov were recruiting at one or more sites in Iowa on 26 Oct 2026. By substance: Ketamine / esketamine 3, Psilocybin 1. By condition: depression 2, alcohol use disorder 2, ocd 1, bipolar disorder 1.
From the ClinicalTrials.gov registry (US National Library of Medicine), read through its public API on 26 Oct 2026: studies marked as recruiting whose interventions name the substance. Titles, sponsors, phases, conditions and sites are the registry's own entries, written by the sponsors. We have not vetted any trial, and recruiting status changes; the registry record and the study team have the current eligibility rules.
Phase 2Ketamine / esketamineNCT02122562
Ketamine Alcohol (in Treatment-Resistant Depression)
- Conditions:
- Magnetic Resonance Imaging; Major Depression; Alcoholism
- Sponsor:
- Mark Niciu
- Who:
- ages 18 Years to 55 Years, 60 participants planned
- University of Iowa Health Care, Iowa City, Iowa
ObservationalKetamine / esketamineNCT04480918
University of Iowa Interventional Psychiatry Service Patient Registry
- Conditions:
- Treatment Resistant Depression; Major Depressive Episode; Major Depression; Major Depressive Disorder; Bipolar Disorder; Bipolar Depression; Obsessive-Compulsive Disorder
- Sponsor:
- Mark Niciu
- Who:
- ages 18 Years to 99 Years, 1000 participants planned
- University of Iowa Health Care, Iowa City, Iowa
Phase 2Psilocybin, Ketamine / esketamineNCT06405607
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial (Psi or Ket)
- Conditions:
- Alcohol Use Disorder; Alcohol Dependence; Alcohol Abuse
- Sponsor:
- University of Iowa
- Who:
- ages 21 Years to 65 Years, 80 participants planned
- University of Iowa Health Care, Iowa City, Iowa